Thermo Fisher Scientific Inc. (NYSE:TMO) will look for mergers and acquisitions (M&A). Marc Casper, Chairman, President and Chief Executive Officer said, Our capital deployment strategy, it remains unchanged, and Stephen is going to go through it in more detail. I'm going to focus on M&A, which will be 60% to 75% of our future capital deployment. Looking at our M&A strategy, it's a very successful one. And it's based on the criteria that we use, which is we want to select the right deals, the deals that enhance our customer offering, strengthen our strategic position and ultimately, create shareholder value. It's a very disciplined process on decision-making, and we have a proven integration approach that translates into enhancing the financial and operational performance of the acquired companies. And that translates into excellent cost and revenue synergies and financial performance overall, creating significant value for our shareholders.